Osaka, Japan

Norimitsu Hariguchi



 

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Tokushima, JP (2015)
  • Kitajima-cho, JP (2018 - 2019)
  • Osaka, JP (2016 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Norimitsu Hariguchi: Innovator in Antibacterial Compounds

Introduction

Norimitsu Hariguchi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at combating tuberculosis. With a total of six patents to his name, Hariguchi's work focuses on innovative solutions to address multidrug-resistant bacterial infections.

Latest Patents

Hariguchi's latest patents include a piperidine derivative designed to provide excellent antibacterial activity against multidrug-resistant tuberculosis bacteria and non-tuberculous acid-fast bacteria. This compound can be utilized for the diagnosis, prevention, and treatment of tuberculosis. Another notable patent involves heterobicyclic compounds that also exhibit strong antibacterial activity against tuberculosis bacteria and multidrug-resistant strains. These compounds are represented by specific chemical formulas detailed in the attached specifications of the patents.

Career Highlights

Throughout his career, Norimitsu Hariguchi has worked with reputable organizations, including Otsuka Pharmaceutical Company and the Educational Foundation Jichi Medical University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Hariguchi's notable coworkers include Makoto Matsumoto and Hiroshi Shimizu. Their collaborative efforts have further advanced the research and development of effective antibacterial compounds.

Conclusion

Norimitsu Hariguchi's innovative work in the field of antibacterial compounds highlights his commitment to addressing critical health challenges. His contributions are vital in the ongoing fight against tuberculosis and multidrug-resistant infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…